0001209191-18-006224.txt : 20180131
0001209191-18-006224.hdr.sgml : 20180131
20180131163819
ACCESSION NUMBER: 0001209191-18-006224
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180129
FILED AS OF DATE: 20180131
DATE AS OF CHANGE: 20180131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KELLOGG PETER N
CENTRAL INDEX KEY: 0001226287
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 18563248
MAIL ADDRESS:
STREET 1: MERCK & CO., INC
STREET 2: ONE MERCK DRIVE., P.O. BOX 100
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889-0100
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-29
0
0000816284
CELGENE CORP /DE/
CELG
0001226287
KELLOGG PETER N
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
0
1
0
0
See Remarks
Stock Option (right to buy)
103.26
2018-01-29
4
A
0
13377
0.00
A
2028-01-29
Common Stock
13377
13377
D
Option is immediately exercisable and will vest as follows: 3,344 shares on January 29, 2019; 3,344 shares on January 29, 2020; 3,344 shares on January 29, 2021; and 3,345 shares on January 29, 2022.
The option was issued pursuant to the Company's 2017 Stock Incentive Plan.
Executive Vice President and Chief Financial Officer
/s/ Peter N. Kellogg
2018-01-31